{"id":76036,"date":"2022-07-20T18:12:10","date_gmt":"2022-07-20T18:12:10","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=95268"},"modified":"2022-07-20T18:12:10","modified_gmt":"2022-07-20T18:12:10","slug":"rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx","status":"publish","type":"post","link":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/","title":{"rendered":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX"},"content":{"rendered":"

NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) —<\/p>\n

WHY:\u00a0<\/strong>Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.\u00a0(NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the \u201cClass Period\u201d). If you wish to serve as lead plaintiff, you must move the Court\u00a0no later than September 16, 2022<\/strong>.<\/p>\n

SO WHAT:<\/strong>\u00a0If you purchased TG Therapeutics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.<\/p>\n

WHAT TO DO NEXT:\u00a0<\/strong>To join the TG Therapeutics class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=7662<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0pkim@rosenlegal.com<\/a>\u00a0or\u00a0cases@rosenlegal.com<\/a>\u00a0for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court\u00a0no later than September 16, 2022<\/strong>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n

WHY ROSEN LAW:\u00a0<\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

DETAILS OF THE CASE:\u00a0<\/strong>According to the lawsuit, throughout the Class Period, defendants made false and\/or misleading statements and\/or failed to disclose that: (1) clinical trials revealed significant concerns related to the benefit-risk ratio and overall survival data of Ublituximab (an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (\u201cCLL\u201d), and relapsing forms of multiple sclerosis) and Umbralisib (or UKONIQ, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma); (2) accordingly, it was unlikely that TG Therapeutics would be able to obtain U.S. Food and Drug Administration (\u201cFDA\u201d) approval of the marginal zone lymphoma (\u201cMZL\u201d) and follicular lymphoma (\u201cFL\u201d) (the \u201cUmbralisib MZL\/FL NDA\u201d), the rolling submission of a Biologics License Application (\u201cBLA\u201d) to the FDA for Ublituximab in combination with Umbralisib (together, \u201cU2\u201d), as a treatment for patients with CLL (the \u201cU2 BLA\u201d), the supplemental New Drug Application (\u201csNDA\u201d) for Umbralisib to add an indication for CLL and small lymphocytic lymphoma (\u201cSLL\u201d) in combination with Ublituximab (the \u201cU2 sNDA\u201d), or the Ublituximab as a treatment for patients with relapsing forms of multiple sclerosis (\u201cRMS\u201d) (the \u201cUblituximab RMS BLA\u201d) in their current forms; (3) as a result, TG Therapeutics had significantly overstated Ublituximab and Umbralisib\u2019s clinical and\/or commercial prospects; and (4) therefore, the Company\u2019s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n

To join the TG Therapeutics class action, go to\u00a0https:\/\/rosenlegal.com\/submit-form\/?case_id=7662<\/a>\u00a0or call Phillip Kim, Esq. toll-free at 866-767-3653 or email\u00a0pkim@rosenlegal.com<\/a>\u00a0or\u00a0cases@rosenlegal.com<\/a>\u00a0for information on the class action.<\/p>\n

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n

Follow us for updates on LinkedIn:\u00a0https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter:\u00a0https:\/\/twitter.com\/rosen_firm<\/a>\u00a0or on Facebook:\u00a0https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

——————————–<\/p>\n

Contact Information:<\/p>\n

Laurence Rosen, Esq.
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\nlrosen@rosenlegal.com<\/a>
\npkim@rosenlegal.com<\/a>
\ncases@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) \u2014 WHY:\u00a0Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.\u00a0(NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the \u201cClass Period\u201d). If you wish to [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,53,343],"tags":[],"yoast_head":"\nROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) \u2014 WHY:\u00a0Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.\u00a0(NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the \u201cClass Period\u201d). If you wish to [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\" \/>\n<meta property=\"og:site_name\" content=\"Lebanon News Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-20T18:12:10+00:00\" \/>\n<meta name=\"author\" content=\"lnadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"lnadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\"},\"author\":{\"name\":\"lnadmin\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840\"},\"headline\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX\",\"datePublished\":\"2022-07-20T18:12:10+00:00\",\"dateModified\":\"2022-07-20T18:12:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\"},\"wordCount\":776,\"publisher\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\"},\"articleSection\":[\"MENA\",\"Pakistan\",\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\",\"url\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\",\"name\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#website\"},\"datePublished\":\"2022-07-20T18:12:10+00:00\",\"dateModified\":\"2022-07-20T18:12:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lebanonnewsgazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#website\",\"url\":\"https:\/\/lebanonnewsgazette.com\/\",\"name\":\"Lebanon News Gazette\",\"description\":\"News from Lebanon\",\"publisher\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lebanonnewsgazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\",\"name\":\"Lebanon News Gazette\",\"url\":\"https:\/\/lebanonnewsgazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png\",\"contentUrl\":\"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png\",\"width\":503,\"height\":261,\"caption\":\"Lebanon News Gazette\"},\"image\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840\",\"name\":\"lnadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"lnadmin\"},\"url\":\"https:\/\/lebanonnewsgazette.com\/author\/lnadmin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/","og_locale":"en_US","og_type":"article","og_title":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette","og_description":"NEW YORK, July 20, 2022 (GLOBE NEWSWIRE) \u2014 WHY:\u00a0Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TG Therapeutics, Inc.\u00a0(NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the \u201cClass Period\u201d). If you wish to [\u2026]","og_url":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/","og_site_name":"Lebanon News Gazette","article_published_time":"2022-07-20T18:12:10+00:00","author":"lnadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"lnadmin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#article","isPartOf":{"@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/"},"author":{"name":"lnadmin","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840"},"headline":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX","datePublished":"2022-07-20T18:12:10+00:00","dateModified":"2022-07-20T18:12:10+00:00","mainEntityOfPage":{"@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/"},"wordCount":776,"publisher":{"@id":"https:\/\/lebanonnewsgazette.com\/#organization"},"articleSection":["MENA","Pakistan","Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/","url":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/","name":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX - Lebanon News Gazette","isPartOf":{"@id":"https:\/\/lebanonnewsgazette.com\/#website"},"datePublished":"2022-07-20T18:12:10+00:00","dateModified":"2022-07-20T18:12:10+00:00","breadcrumb":{"@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lebanonnewsgazette.com\/rosen-respected-investor-counsel-encourages-tg-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-tgtx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lebanonnewsgazette.com\/"},{"@type":"ListItem","position":2,"name":"ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc.\u00a0Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TGTX"}]},{"@type":"WebSite","@id":"https:\/\/lebanonnewsgazette.com\/#website","url":"https:\/\/lebanonnewsgazette.com\/","name":"Lebanon News Gazette","description":"News from Lebanon","publisher":{"@id":"https:\/\/lebanonnewsgazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lebanonnewsgazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lebanonnewsgazette.com\/#organization","name":"Lebanon News Gazette","url":"https:\/\/lebanonnewsgazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png","contentUrl":"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png","width":503,"height":261,"caption":"Lebanon News Gazette"},"image":{"@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840","name":"lnadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"lnadmin"},"url":"https:\/\/lebanonnewsgazette.com\/author\/lnadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts\/76036"}],"collection":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/comments?post=76036"}],"version-history":[{"count":0,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts\/76036\/revisions"}],"wp:attachment":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/media?parent=76036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/categories?post=76036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/tags?post=76036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}